15 studies found for:    TUBULIN, BETA
Show Display Options
Rank Status Study
1 Active, not recruiting Personalized Therapy in Non-small Cell Lung Cancer
Conditions: Lung Cancer;   Carboplatin Adverse Reaction
Intervention: Drug: carboplatin, gemcitabine,pemetrexed,docetaxel
2 Active, not recruiting
Has Results
ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment
Conditions: Disseminated Neuroblastoma;   Recurrent Neuroblastoma
Interventions: Drug: ABT-751;   Procedure: quality-of-life assessment
3 Completed ABT-751 in Treating Young Patients With Refractory Solid Tumors
Conditions: Brain and Central Nervous System Tumors;   Childhood Germ Cell Tumor;   Extragonadal Germ Cell Tumor;   Kidney Cancer;   Liver Cancer;   Neuroblastoma;   Ovarian Cancer;   Sarcoma;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Drug: ABT-751
4 Terminated Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory Cancer
Condition: Neoplasms
Intervention: Drug: SSR97225
5 Recruiting Preoperative TPF Chemotherapy in a Population of Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer
Condition: Locally Advanced Resectable Oral Cavity Squamous Cell Cancer
Intervention: Drug: docetaxel, cisplatin, 5 fluorouracil
6 Completed A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies
Condition: Sarcoma
Interventions: Drug: OMBRABULIN (AVE8062);   Drug: Placebo
7 Terminated A Trial of ALB 109564(a) in Subjects With Advanced Solid Tumors
Condition: Cancer
Intervention: Drug: ALB 109564(a) (12´-methylthiovinblastine dihydrochloride)
8 Recruiting A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific;   Gastric Cancer;   Breast Cancer
Intervention: Drug: KX2-391 and Paclitaxel
9 Recruiting Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC
Conditions: Breast Neoplasms;   Neoplasms by Site;   Neoplasm Metastasis;   Breast Diseases;   Skin Diseases
Interventions: Drug: Docetaxel plus Capecitabine;   Drug: Capecitabine
10 Completed LEVANT I, The Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropoliteal Restenosis
Conditions: Atherosclerosis;   Vascular Disease;   Arteriosclerosis
Interventions: Device: Lutonix Catheter;   Device: Standard uncoated Balloon Angioplasty Catheter
11 Active, not recruiting JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin
Condition: Bladder Transitional Cell Carcinoma Stage IV
Interventions: Drug: Vinflunine, Gemcitabine;   Drug: Vinflunine, Carboplatin
12 Completed A Trial to Evaluate Epothilone D in Patients With Advanced Solid Tumors
Condition: Neoplasms
Intervention: Drug: Epothilone D (KOS-862)
13 Completed Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: CKD-516 inj
14 Completed Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies
Conditions: Neoplasms;   Hodgkin's Disease;   Non-Hodgkin's Lymphoma
Intervention: Drug: TPI 287 Injection
15 Completed Study of TPI 287 in Patients With Advanced Malignancies
Conditions: Neoplasms;   Non-Hodgkin Lymphoma;   Hodgkin Disease
Intervention: Drug: TPI 287 Injection

Indicates status has not been verified in more than two years